AnteoTech Limited announce three new senior appointments. Joining AnteoTech on 6 December as Head of Market Operations ? Life Sciences, Ian Steinhardt will be responsible for executing the Company's global sales and distribution strategy across the Life Sciences division, focusing on the EuGeni Rapid Diagnostic platform. Ian has worked in sales and marketing roles for Sanofi Diagnostics Pasteur and most recently as Enterprise Account Manager for Abbott Diagnostics in Australia. Pierre Nathie joins AnteoTech as Head of Product & Services ? Life Sciences and will be charged with the development of the Company's global product marketing strategy across Assay Development (EuGeni), Raw Materials (AnteoBind) and Assay Services. Critically, Pierre will take responsibility for planning and commercial execution of new products including new tests on the EuGeni platform and the associated validation and regulatory cycles of all products. Pierre has held senior positions within BD Diagnostics in Paris and the United Kingdom, most recently, he held the position of Business Development Manager for Universal Biosensors in Melbourne and Managing Director of Med2Mark. Pierre will join AnteoTech on the 8th of November 2021. Mr. Tim Pritchard will commence as Chief Financial Officer and Company Secretary, on 1 November, taking over from Mr. Duncan Cornish. Duncan will continue in the role of Company Secretary until the end of November 2021 in order to effect a handover. Before joining AnteoTech, Tim was engaged as the Chief Financial Officer and Company Secretary of Leaf Resources and prior to that, as Chief Financial Officer and Company Secretary of ReNu Energy.